Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval

被引:38
|
作者
Ogilvie, Gina S. [1 ,2 ,8 ]
Smith, Laurie W. [3 ]
van Niekerk, Dirk [3 ]
Khurshed, Fareeza [3 ]
Pedersen, Heather N. [1 ]
Taylor, Darlene [4 ]
Thomson, Katharine
Greene, Sandra B. [5 ]
Babich, Suzanne M. [6 ]
Franco, Eduardo L. [7 ]
Coldman, Andrew J. [1 ,4 ]
机构
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Womens Hlth Res Inst, Vancouver, BC, Canada
[3] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[4] British Columbia Ctr Dis Control, Vancouver, BC, Canada
[5] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
[6] Indiana Univ Purdue Univ, Richard M Fairbanks Sch Publ Hlth, Indianapolis, IN 46202 USA
[7] McGill Univ, Montreal, PQ, Canada
[8] BC Womens Hosp & Hlth Ctr, Room H203G,4500 Oak St, Vancouver, BC V6H 3N1, Canada
基金
加拿大健康研究院;
关键词
Cervical cancer; Human papillomavirus; Theory of planned behaviour; Screening programs; RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; HPV; CYTOLOGY; BELIEFS; PREVENTION; MANAGEMENT; KNOWLEDGE; ATTITUDES; DNA;
D O I
10.1186/s12889-016-2865-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screening (HPV-CCS) as an alternative to the Papanicolaou cytology-method. This study describes factors associated with women's intentions to attend cervical cancer screening if high-risk HPV DNA testing (HPV-CCS) was implemented as a primary screening tool, and if screening were conducted every 4 years starting after age 25. Methods: This online survey was designed using the Theory of Planned Behaviour to assess factors that impact women's intentions to attend HPV-CCS among women aged 25-69 upon exit of the HPV FOCAL trial. Univariate and regression analyses were performed to compare the demographic, sexual history, and smoking characteristics between women willing and unwilling to screen, and scales for intention to attend HPV-CCS. A qualitative analysis was performed by compiling and coding the comments section of the survey. Results: Of the 981 women who completed the survey in full, only 51.4 % responded that they intended to attend HPV-CCS with a delayed start age and extended screening interval. Women who intended to screen were more likely to have higher education (AOR 0.59, 95 % CI [0.37, 0.93]), while both positive attitudes (AOR 1.26, 95 % CI [1.23, 1.30]) and perceived behavior control (AOR 1.06, 95 % CI [1.02, 1.10]) were significant predictors of intention to screen. Among women who provided comments in the survey, a large number of women expressed fears about not being checked more than every 4 years, but 12 % stated that these fears may be alleviated by having more information. Conclusions: Acceptability of increased screening intervals and starting age could be improved through enhanced education of benefits. Program planners should consider measures to assess and improve women's knowledge, attitudes and beliefs prior to the implementation of new screening programs to avoid unintended consequences.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] The recommended interval for cervical cancer screening: Victorian women's attitudes to an extended interval
    Scalzo, Katherine
    Mullins, Robyn
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2015, 39 (02) : 153 - 156
  • [22] Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial
    Isidean, Sandra D.
    Mayrand, Marie-Helene
    Ramanakumar, Agnihotram V.
    Gilbert, Laura
    Reid, Stephanie L.
    Rodrigues, Isabel
    Ferenczy, Alex
    Ratnam, Sam
    Coutlee, Francois
    Franco, Eduardo L.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (11) : 2456 - 2466
  • [23] The advent of human papillomavirus detection for cervical screening
    Morris, Brian J.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2019, 31 (05) : 333 - 339
  • [24] Cervical cancer and human papillomavirus in indigenous Guyanese women
    Kightlinger, Rebecca S.
    Irvin, William P.
    Archer, Kellie J.
    Huang, Nancy W.
    Wilson, Raeleen A.
    Doran, Jacqueline R.
    Quigley, Neil B.
    Pinkerton, JoAnn V.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 202 (06) : 626.e1 - 626.e7
  • [25] Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana
    Awua, A. K.
    Sackey, S. T.
    Osei, Y. D.
    Asmah, R. H.
    Wiredu, E. K.
    INFECTIOUS AGENTS AND CANCER, 2016, 11
  • [26] Effects of Human Papillomavirus Awareness and Knowledge on Psychological State of Women Referred to Cervical Cancer Screening
    Markovic-Denic, Ljiljana
    Djuric, Olivera
    Maksimovic, Natasa
    Popovac, Svetlana
    Kesic, Vesna
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2018, 22 (03) : 178 - 183
  • [27] Human Papillomavirus Testing in Cervical Cancer Screening
    Castle, Philip E.
    Cremer, Miriam
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2013, 40 (02) : 377 - +
  • [28] Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer Screening
    Volesky, Karena D.
    Magnan, Sindy
    Mayrand, Marie-Helene
    Isidean, Sandra D.
    El-Zein, Mariam
    Comete, Emilie
    Franco, Eduardo L.
    Coutlee, Francois
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (04) : 851 - 857
  • [29] Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial
    Cook, Darrel A.
    Krajden, Mel
    Brentnall, Adam R.
    Gondara, Lovedeep
    Chan, Tracy
    Law, Jennifer H.
    Smith, Laurie W.
    van Niekerk, Dirk J.
    Ogilvie, Gina S.
    Coldman, Andrew J.
    Warman, Rhian
    Reuter, Caroline
    Cuzick, Jack
    Lorincz, Attila T.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (10) : 2587 - 2595
  • [30] Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
    Sasaki, Yuri
    Iwanari, Osamu
    Arakawa, Ichiro
    Moriya, Takuya
    Mikami, Yoshiki
    Iihara, Kuniko
    Konno, Ryo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (03) : 523 - 529